Trial Identifier: | D7860C00004 |
Sponsor: | AstraZeneca |
Start Date: | July 2024 |
Primary Completion Date: | October 2024 |
Study Completion Date: | October 2024 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
DE | Berlin, DE, 14050 |